The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraime Ord Regulatory News (BMTO)

Share Price Information for Braime Ord (BMTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,850.00
Bid: 1,700.00
Ask: 2,000.00
Change: 0.00 (0.00%)
Spread: 300.00 (17.647%)
Open: 1,850.00
High: 1,850.00
Low: 1,850.00
Prev. Close: 1,850.00
BMTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results for six months ended 30 June 2021

8 Sep 2021 16:04

RNS Number : 1662L
Braime Group PLC
08 September 2021
 

Braime Group PLC

("Braime" or the "Company" and together with its subsidiaries the "Group")

 

Interim Results for the six months ended 30th June 2021

 

 

The Company presents its unaudited interims results for the six months ended 30 June 2021:

 

Performance

Group sales revenue for the first six months of 2021 increased by 13% to £18.2m when compared to £16.1m for the same period in 2020, while profit before tax increased to £885,000 compared to £372,000 for the same period in 2020. The retained profit for the six-month period includes a £250,000 provision for repairs commitments to our chain cell operations which has become necessary while the new warehouse is being built. The directors are pleased to report that following the upheaval of the previous year brought about by the global pandemic, the Group has seen a surge in customer demand which began in the spring of 2021, with all sectors performing strongly, particularly the automotive sector. The underlying trading performance of the Group should also be viewed from the context of Sterling strengthening during 2021. A significant proportion of the Group's income is earned in the USA, and consequently, Sterling strengthening against the US dollar (a closing rate of 1:1.389 as at June 2021 compared to 1:1.236 in June 2020) results in a reduction in profit for the Group when reported in Sterling.

 

Dividends

In line with the Group's policy to maintain dividend growth, balanced alongside the Group's requirement for investment in capital to support long term growth, the directors have decided to increase the interim dividend from 4.00p to 4.25p per share. This dividend will be paid on 14th October 2021 to the Ordinary and 'A' Ordinary shareholders on the register on the 1st October 2021. The associated ex-dividend date is 30th September 2021.

 

Braime Pressings Limited

External sales revenue of £2.6m in the first 6 months of 2021 was 35% up on the same period last year driven by strong demand from the automotive sector. Intercompany sales also increased by £238,000. The manufacturing division made a profit before tax of £481,000 as a result of the higher demand for its products. As reported last year, the Company recruited a new sales manager at the beginning of 2020 and after a challenging year the Company is now developing new sectors.

 

4B Division

Our distribution division's external sales revenue of £15.6m increased by 10% when compared to £14.2m for the same period last year. Intercompany trading increased by 9.8% to £2.6m (£2.4m for the same period in 2020). The division has benefitted from an exceptional order of chain products from the Middle East early in the year. The £1.4m increase in external sales has had a positive direct impact on profitability, with profit after tax for the 4B division for the six-month period increasing to £494,000 as compared to £307,000 for the same period last year.

 

Balance Sheet

Total net assets as at 30th June 2021 amounted to £15.4m (30th June 2020 - £14.9m). Capital asset additions of £991,000 during the period relate to a large extent to the remainder of the €2.2m construction costs of the warehouse being £433,000 for 4B France which was fully completed in May 2021 as announced earlier in the year. As announced last month, the Company has also commenced construction of a new climate-controlled warehouse and additional parking facilities at our head office facility in Leeds, UK which is anticipated to cost £1m and is being funded primarily from a £850,000 development loan from the Company's bankers. At the half-year, the Group had spent £185,000 on improvements to its head office facilities. Other investments relate to various items of manufacturing equipment and other IT capital expenditure.

 

Inventory has decreased by £44,000 when compared to 30th June 2020 and increased by £219,000 when compared to 31st December 2020. Trade receivables of £7.5m have increased by £918,000 when compared to 30th June 2020 and increased by £1,518,000 when compared to 31st December 2020. The increase in trade debtors are a direct result of the increase in revenue in the first six months of 2021 and is in line with seasonal trend. Overall debtor days are similar to prior periods. The increase in long-term borrowings during the year are in line with expectations, being the take up of new loans of £532,000 in relation to the final draw-down of the €1.7m loan facility in 4B France with Credit du Nord and BPI-France which, as mentioned in the 2019 annual report, was obtained to fund the warehouse construction (the balance having been funded out of profit).

 

Cash flow

Cash at the end of the period was £764,000. Cash generated from operations before working capital movements was £1.3m during the period. An increase in trade receivables of £1,518,000, an increase in inventories of £219,000 offset by an increase in trade payables of £1,138,000 saw working capital reduce by £599,000 since the year end. These are a consequence of the increased level of trading activity during the period. Investment in capital projects mentioned above gave rise to capital outflows of £991,000 and the Group repaid £234,000 of loans whilst the take up of new loans of £532,000 in France mentioned above, provided proceeds from borrowings. Overall, net cash reduced by £433,000 during the six months to 30th June 2021. The business has sufficient headroom within its £3.5m bank overdraft facility and management remains focused in ensuring that working capital requirements, particularly for stock, are carefully monitored and controlled.

 

Principal exchange rates

The Group reports its results in Sterling, its presentational currency. The Group operates in six other currencies and the average of the principal exchange rates in use during the half year and as at 30th June 2021 are shown in the table below, along with comparatives. Since a significant proportion of the Group revenues are in the USA, the Group has incurred foreign exchange losses from the strengthening of Sterling against the US dollar since 31st December 2020.

 

 

Currency

 

Symbol

Avg rate

HY 2021

Avg rate

HY 2020

Avg rate

FY 2020

Closing rate

30th Jun 2021

Closing rate

30th Jun 2020

Closing rate

31st Dec 2020

Australian Dollar

AUD

1.813

1.922

1.867

1.840

1.795

1.763

Chinese Renminbi (Yuan)

CNY

8.993

8.857

8.880

8.941

8.714

8.890

Euro

EUR

1.156

1.140

1.126

1.165

1.100

1.112

South African Rand

ZAR

20.257

21.334

21.309

19.711

21.468

20.030

Thai Baht

THB

43.064

39.993

40.404

44.290

38.152

40.838

United States Dollar

USD

1.389

1.259

1.290

1.382

1.236

1.365

 

Key performance indicators

The Group uses the following key performance indicators to assess the performance of the Group as a whole and of the individual businesses:

 

 

Key performance indicator

 

Note

 

Half year 

2021 

 

Half year 

2020 

 

Full year 

2020 

Turnover growth

1

13.0% 

(5.6%)

(1.9%) 

Gross margin

2

47.2% 

47.4% 

46.7%

Operating profit

3

£0.98m 

£0.45m 

£1.38m

Stock days

4

170 days 

191 days 

182 days

Debtor days

5

59 days 

63 days 

56 days

 

Notes to KPI's

1. Turnover growth

The Group aims to increase shareholder value by measuring the year on year growth in Group revenue. Revenues are up due to the strong demand in the manufacturing sector and improvements in the global economic climate as the impact of the COVID pandemic recedes.

 

2. Gross margin

Gross profit (revenue less change in inventories and raw materials used) as a percentage of revenue is monitored to maximise profits available for reinvestment and distribution to shareholders. Gross margin has decreased slightly over the same period last year but has improved when compared to the full year results in 2020. The directors continue to monitor the margins carefully for further movement.

 

3. Operating profit

Sustainable growth in operating profit is a strategic priority to enable ongoing investment and increase shareholder value. Operating profits have improved as a direct result of the increase in sales in both the manufacturing and the 4B division.

 

4. Stock days

The average value of inventories divided by raw materials and consumables used and changes in inventories of finished goods and work in progress expressed as a number of days is monitored to ensure the right level of stocks are held in order to meet customer demands whilst not carrying excessive amounts which impacts upon working capital requirements. Stock days have reduced with sales increasing but inventories remaining largely unchanged.

 

5. Debtor days

The average value of trade receivables divided by revenue expressed as a number of days. This is an important indicator of working capital requirements. Debtor days at 59 days are slightly below the standard payment terms of 60 days. Management remain focused on reducing this to improve cash.

 

Other metrics monitored weekly or monthly include quality measures (such as customer complaints), raw materials buying prices, capital expenditure, line utilisation, reportable accidents and near-misses.

 

Ongoing impact of the COVID pandemic

Due to the support of our staff, the business succeeded in operating throughout the pandemic, with only limited numbers working from home, where possible. With the exception of our staff at 4B Asia Pacific, "normal work" patterns have returned across the group, while we continue to act cautiously to try to minimise the effects of the ongoing epidemic. Nevertheless, our sales activities continue to be negatively affected by the remaining travel restrictions and the lack of trade exhibitions, both of which greatly limit our ability to engage with our customers.

 

While we have adopted new means of marketing during the pandemic, these do not replace the benefits of direct contact with our customers. This direct contact has always been central to our process of continuously developing new product and of bringing these products to market. We hope that our ability to visit our customers and display our products at trade exhibitions will gradually become possible in the coming months.

 

Short term Impact of Brexit

The group is heavily dependent on the import of raw materials to manufacture our products, and on the import of finished product, both of which are then exported globally, and a large proportion of group sales are made in sales to overseas markets. Our trained and experienced staff were able to make and automate the relatively simple changes to our existing documentation required to continue our exports to the EU. Where we were able to deliver in full truck loads, our exports to the EU continued almost seamlessly.

 

However, where we had to ship part loads on trucks, shared with UK exporters who were less familiar with export documentation, our own deliveries were significantly delayed by incorrect or incomplete documentation provided by other exporters. We were also taken by surprise by the lack of knowledge within many European freight companies. No doubt this lack of preparedness was caused by the months, and indeed years, of uncertainty and political brinkmanship and by the last-minute nature of the Trade Agreement. We have now largely adapted to this situation by re-scheduling our exports and delivering on dedicated trucks wherever possible, and by switching to more competent international freight companies.

 

Outlook for the second half of 2021

We are benefitting from a large increase in the volume of sales, due in part to the Brexit Bounce, and, in part, due to the ongoing introduction of new products. The benefits of this increase in the volume of sales are tempered by the quite unprecedented rise in the cost of many key raw materials, including steel and plastic resin, which have both increased by around 35% and also by an equally unprecedented jump in the cost of freight, particularly sea freight, which affects both import and export. In some case, the cost of freight is 700% higher than 12 months ago.

 

Both inflationary problems will reduce our margins in the short term. We are trying to pass on increases to our customers, but there is an inevitable delay in this process. Meanwhile these price increases will almost certainly lead eventually to a drop in the volume of sales. The huge increase in the cost of delivering goods over long distances, creates major challenges for our export focused group - but also creates potential new opportunities, for our manufacturing business.

 

 

For further information please contact:

 

Nicholas Braime/Cielo Cartwright

0113 245 7491

 

W. H. Ireland Limited

Katy Mitchell

0113 394 6628

 

 

Braime Group PLC

Consolidated income statement for the six months

ended 30th June 2021

 

 

 

Note

Unaudited 6 months to 

30th June 2021 

Unaudited 6 months to 

30th June 2020 

Audited 

year to 

31st December 

2020 

£'000 

£'000 

£'000 

Revenue

 18,212 

16,114 

32,803 

Changes in inventories of finished goods and work in progress

 

 51 

 

492 

 

(63)

Raw materials and consumables used

(9,661)

(8,954)

(17,428)

Employee benefits costs

(4,366)

(4,406)

(8,408)

Depreciation expense

(655)

(646)

(1,280)

Other expenses

(2,597)

(2,146)

(4,277)

Other operating income

30 

Profit from operations

989 

454 

1,377 

Finance costs

(106)

(82)

(191)

Finance income

Profit before tax

885 

372 

1,195 

Tax expense

(220)

(114)

(341)

Profit for the period

665 

258 

854 

Profit attributable to:

Owners of the parent

608 

242 

823 

Non-controlling interests

57 

16 

31 

665 

258 

854 

Basic and diluted earnings per share

2

46.18p 

16.81p 

59.31p 

 

 

Braime Group PLC

Consolidated statement of comprehensive income for the six months

ended 30th June 2021

Unaudited 

6 months to 

 30th June 

2021 

Unaudited 

6 months to 

 30th June 

2020 

Audited 

year to 

31st December 

2020 

£'000 

£'000 

£'000 

Profit for the period

665

258 

854 

Items that will not be reclassified subsequently to profit or loss

Net pension remeasurement gain on post-employment benefits

66 

Items that may be reclassified subsequently to profit or loss

Foreign exchange (losses)/gains on re-translation of overseas operations

(97)

404 

(133)

Other comprehensive income for the period

(97)

404 

(67)

Total comprehensive income for the period

568 

662 

787 

Total comprehensive income attributable to:

Owners of the parent

489 

656 

744 

Non-controlling interests

79 

43 

568 

662 

787 

 

The foreign currency movements arise on the re-translation of overseas subsidiaries' opening balance sheets at closing rates.

 

Braime Group PLC

Consolidated balance sheet at 30th June 2021

Unaudited

6 months to

30th June

2021

Unaudited

6 months to

30th June

2020

Audited

year to 31st 

December 

2020 

£'000

£'000

£'000 

Non-current assets

Property, plant and equipment

8,216 

7,246 

7,830 

Intangible assets

31 

44 

37 

Right of use assets

683 

190 

487 

Total non-current assets

8,930 

7,480 

8,354 

Current assets

Inventories

9,083 

9,127 

8,864 

Trade and other receivables

7,472 

6,554 

5,855 

Cash and cash equivalents

1,673 

1,558 

1,533 

Total current assets

18,228 

17,239 

16,252 

Total assets

27,158 

24,719 

24,606 

Current liabilities

Bank overdraft

909 

736 

335 

Trade and other payables

5,344 

4,586 

4,744 

Other financial liabilities

2,661 

2,042 

2,133 

Corporation tax liability

70 

47 

78 

Total current liabilities

8,984 

7,411 

7,290 

Non-current liabilities

Financial liabilities

2,479 

2,031 

2,075 

Deferred income tax liability

276 

382 

278 

Total non-current liabilities

2,755 

2,413 

2,353 

Total liabilities

11,739 

9,824 

9,643 

Total net assets

15,419 

14,895 

14,963 

Capital and reserves

Share capital

360 

360 

360 

Capital reserve

257 

257 

257 

Foreign exchange reserve

(270)

408 

(151)

Retained earnings

15,296 

14,211 

14,800 

Total equity attributable to the shareholders of the parent company

15,643 

 15,236 

15,266 

Non-controlling interests

(224)

(341)

(303)

Total equity

15,419 

14,895 

14,963 

 

 

 

Braime Group PLC

Consolidated cash flow statement for the six months

ended 30th June 2021

 

 

 

Note

Unaudited 

6 months to 

30th June 

2021 

Unaudited 

6 months to 

30th June 

2020 

Audited 

year to 

31st December 

2020 

£'000 

£'000 

£'000

Operating activities

Net profit

665 

258 

854 

Adjustments for:

Depreciation

655 

646 

1,280 

Foreign exchange (losses)/gains

(4)

299 

(170)

Finance income

(2)

(9)

Finance expense

106 

82 

191 

(Gain)/loss on sale of plant, machinery and motor vehicles

(5)

 1 

Adjustment in respect of defined benefit scheme

71 

Income tax expense

220 

114 

341 

Income taxes paid

(329)

(8)

(168)

Operating profit before changes in working capital and provisions

 

1,306 

 

1,391 

 

2,391 

Increase in trade and other receivables

(1,518)

(915)

(356)

Increase in inventories

(219)

(554)

(291)

Increase in trade and other payables

1,138 

787 

942 

(599)

(682)

295 

Cash generated from operations

707 

709 

2,686 

Investing activities

Purchases of property, plant, machinery and motor vehicles

(991)

(855)

 (2,057)

Sale of plant, machinery and motor vehicles

13 

Interest received

(984)

(847)

(2,040)

Financing activities

Proceeds from long term borrowings

532 

900 

1,117 

Repayment of borrowings

(234)

(116)

(419)

Repayment of hire purchase creditors

(109)

(118)

(217)

Repayment of lease liabilities

(127)

(172)

(228)

Bank interest paid

(55)

(63)

(124)

Lease interest paid

(37)

(12)

(38)

Hire purchase interest paid

(15)

(7)

(29)

Dividends paid

(112)

(115)

(173)

(157)

297 

(111)

(Decrease)/increase in cash and cash equivalents

(434)

159 

535 

Cash and cash equivalents, beginning of period

1,198 

663 

663 

Cash and cash equivalents (including overdrafts), end of period

 

3

 

764 

 

822 

 

1,198 

 

 

Braime Group PLC

Consolidated statement of

changes in equity for the

six months ended

30th June 2021

 

 

 

Share 

Capital 

 

 

 

Capital 

Reserve 

 

 

Foreign 

Exchange 

Reserve 

 

 

 

Retained 

Earnings 

 

 

 

 

Total 

 

 

 

Minority 

Interests 

 

 

 

Total 

Equity 

£'000 

£'000 

£'000 

£'000 

£'000 

£'000 

£'000 

Balance at 31st December

2020

 

360 

 

257 

 

(151)

 

14,800 

 

15,266 

 

(303)

 

14,963 

Comprehensive income

Profit

608 

608 

57 

665 

Other comprehensive income

Foreign exchange (loss)/gain

on re-translation of overseas operations

 

 

 

 

 

 

(119)

 

 

 

 

(119)

 

 

22 

 

 

(97)

Total other comprehensive

income

 

 

 

(119)

 

 

(119)

 

22 

 

(97)

Total comprehensive

income

 

 

 

(119)

 

608

 

489 

 

79 

 

568 

Transactions with owners

Dividends

(112)

(112)

(112)

Total transactions with owners

(112)

(112)

(112)

Balance at 30th June 2021

360 

257 

(270)

15,296 

15,643 

(224)

15,419 

 

 

Braime Group PLC

Consolidated statement of

changes in equity for the

six months ended

30th June 2020

 

 

 

Share 

Capital 

 

 

 

Capital 

Reserve 

 

 

Foreign 

Exchange 

Reserve 

 

 

 

Retained 

Earnings 

 

 

 

 

Total 

 

 

 

Minority 

Interests 

 

 

 

Total 

Equity 

£'000 

£'000 

£'000 

£'000 

£'000 

£'000 

£'000 

Balance at 31st December 2019

 

360 

 

257 

 

(6)

 

14,084 

 

14,695 

 

(346)

 

14,349 

Comprehensive income

Profit

242 

242 

16 

258 

Other comprehensive income

Foreign exchange gain/(loss) on re-translation of overseas

operations

 

 

 

 

 

 

414 

 

 

 

 

414 

 

 

(11)

 

 

403 

Total other comprehensive

income

 

 

 

414 

 

 

414 

 

(11)

 

403 

Total comprehensive

income

 

 

 

414 

 

242 

 

656 

 

 

661 

Transactions with owners

Dividends

(115)

(115)

(115)

Total transactions with owners

 

 

 

 

(115)

 

(115)

 

 

(115)

Balance at 30th June 2020

360 

257 

408 

14,211 

15,236 

(341)

14,895 

 

Braime Group PLC

Consolidated statement of

changes in equity for the

year ended 31st December

2020

 

 

 

Share 

Capital 

 

 

 

Capital 

Reserve 

 

 

Foreign 

Exchange 

Reserve 

 

 

 

Retained 

Earnings 

 

 

 

 

Total 

 

 

 

Minority 

Interests 

 

 

 

Total 

Equity 

£'000 

£'000

£'000 

£'000 

£'000 

£'000 

£'000 

Balance at 1st January 2020

360 

257 

(6)

14,084 

14,695 

(346)

14,349 

Comprehensive income

Profit

823 

823 

31 

854 

Other comprehensive income

Net pension remeasurement

gain recognised directly in

equity

 

 

 

 

 

 

 

 

66 

 

 

66 

 

 

 

 

66 

Foreign exchange losses on

re-translation of overseas

operations

 

 

 

 

 

 

(145)

 

 

 

 

(145)

 

 

12 

 

 

(133)

Total other comprehensive

income

 

 

 

(145)

 

66 

 

(79)

 

12 

 

(67)

Total comprehensive

income

 

 

 

(145)

 

889 

 

744 

 

43 

 

787 

Transactions with owners

Dividends

(173)

(173)

(173)

Total transactions with owners

 (173)

 (173)

 (173)

Balance at 31st December

2020

 

360 

 

257 

 

(151)

 

14,800 

 

15,266 

 

(303)

 

14,963 

1. Accounting policies

Basis of preparation

The interim financial report has been prepared using accounting policies that are consistent with those used in the preparation of the full financial statements to 31st December 2020 and those which management expects to apply in the Group's full financial statements to 31st December 2021.

 

This interim financial report is unaudited. The comparative financial information set out in this interim financial report does not constitute the Group's statutory accounts for the period ended 31st December 2020 but is derived from the accounts. Statutory accounts for the period ended 31st December 2020 have been delivered to the Registrar of Companies. The auditors have reported on those accounts. Their audit report was unqualified and did not contain any statements under Section 498 of the Companies Act 2006.

 

The Group's condensed interim financial information has been prepared in accordance with International Financial Reporting Standards ('IFRS') as adopted for the use in the European Union and in accordance with IAS 34 'Interim Financial Reporting' and the accounting policies included in the Annual Report for the year ended 31st December 2020, which have been applied consistently throughout the current and preceding periods. The Group has adopted the following new or amended standards as of 1st January 2021 -

 

· Amendments to IFRS9, IAS39, IFRS7, IFRS4 and IFRS16 - Interest rate benchmarks - introduces practical expedient and exemptions from hedge accounting requirements - effective accounting periods beginning on or after 1 January 2021

 

The application and interpretations surrounding the new or amended standards is not expected to have a material impact on the Group's reported financial performance or position. However, they may give rise to additional disclosures being made in the financial statements.

 

2. Earnings per share and dividends

Both the basic and diluted earnings per share have been calculated using the net results attributable to shareholders of Braime Group PLC as the numerator.

 

The weighted average number of outstanding shares used for basic earnings per share amounted to 1,440,000 (2020 - 1,440,000). There are no potentially dilutive shares in issue.

 

6 months to 

30th June 

2021 

£'000 

Dividends paid on equity shares

Ordinary shares

Interim of 7.80p per share paid on 25th May 2021

37 

'A' Ordinary shares

Interim of 7.80p per share paid on 25th May 2021

75 

Total dividends paid

112 

Year to

31st December 

2020 

£'000 

Dividends paid on equity shares

Ordinary shares

Interim of 8.00p per share paid on 5th June 2020

38 

Interim of 4.00p per share paid on 16th October 2020

19 

57 

'A' Ordinary shares

Interim of 8.00p per share paid on 5th June 2020

77 

Interim of 4.00p per share paid on 16th October 2020

39 

116 

Total dividends paid

173 

 

3. Cash and cash equivalents

 Unaudited 

6 months to 

30th June 

2021 

 Unaudited 

6 months to 

30th June 

2020 

Audited 

year to 

31st December 

2020 

£'000 

£'000 

£'000 

Cash at bank and in hand

1,673 

1,558 

1,533 

Bank overdrafts

(909)

(736)

(335)

764 

822 

1,198 

 

4. Segmental information

Unaudited 6 months to 

30th June 2021 

Central 

Manufacturing

Distribution 

Total 

£'000 

£'000 

£'000 

£'000 

Revenue

External

2,642 

15,570 

18,212 

Inter company

1,006 

1,933 

2,615 

5,554 

Total

1,006 

4,575 

18,185

23,766 

Profit

EBITDA

36

517 

1,091 

1,644 

Finance costs

(34)

(17)

(55)

(106)

Finance income

Depreciation

(296)

(19)

(340)

(655)

Tax expense

(16)

(204)

(220)

(Loss)/profit for the period

(310)

481 

494 

665 

Assets

Total assets

5,512 

5,895 

15,751 

27,158 

Additions to non-current assets

379 

11 

942 

1,332 

Liabilities

Total liabilities

888 

3,141 

7,710 

11,739 

 

Unaudited 6 months to 

 30th June 2020 

Central 

Manufacturing

Distribution 

Total 

£'000 

£'000 

£'000 

£'000 

Revenue

External

1,953 

14,161 

16,114 

Inter company

1,016 

1,695 

2,381 

5,092 

Total

1,016 

3,648 

16,542 

21,206 

Profit

EBITDA

352 

(18)

767

1,101 

Finance costs

(53)

(15)

(14) 

(82)

Finance income

Depreciation

(300)

(11)

(335)

(646)

Tax expense

(14)

10 

(111)

(115)

(Loss)/profit for the period

(15)

(34)

307 

258 

Assets

Total assets

5,449 

4,551 

14,719 

24,719 

Additions to non-current assets

242 

634 

878 

Liabilities

Total liabilities

926 

2,384 

6,514 

9,824 

 

Audited year to 

31st December 2020 

Central 

Manufacturing

Distribution 

Total 

£'000 

£'000 

£'000 

£'000 

Revenue

External

3,762 

29,041 

32,803 

Inter company

1,772 

3,068 

5,159 

9,999 

Total

1,772 

6,830 

34,200 

42,802 

Profit

EBITDA

309 

(163)

2,511 

2,657 

Finance costs

(105)

(31)

(55)

(191)

Finance income

Depreciation

(592)

(28)

(660)

(1,280)

Tax expense

32 

(373)

(341)

(Loss)/profit for the period

(356)

(215)

1,425 

854 

Assets

Total assets

5,178 

4,200 

15,228 

24,606 

Additions to non-current assets

415 

54 

2,020 

2,489 

Liabilities

Total liabilities

801 

2,025 

6,817 

9,643 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR ZVLFBFKLEBBK
12
Date   Source Headline
22nd Apr 20247:00 amRNSANNUAL RESULTS YEAR ENDED 31ST DECEMBER 2023
4th Sep 20234:34 pmRNSInterim Results
23rd Jun 202312:41 pmRNSResult of AGM
24th Apr 202310:03 amRNSAnnual Results for the Year Ended 31 December 2022
19th Apr 20235:39 pmRNSDirectorate Changes
30th Jan 202311:26 amRNSBoard Changes
5th Sep 202212:20 pmRNSInterim Results for Six Months Ended 30 June 2022
24th Jun 20227:00 amRNSResults of Annual General Meeting
22nd Jun 20227:00 amRNSChain Cell Project Update
28th Apr 20227:00 amRNSAnnual Results for the Year Ended 31 December 2021
24th Feb 20227:00 amRNSWarehouse Update
8th Sep 20214:04 pmRNSInterim Results for six months ended 30 June 2021
18th Aug 20213:31 pmRNSLoan Agreement
25th Jun 20215:23 pmRNSResult of AGM
16th Jun 202112:07 pmRNSUpdate on AGM Arrangements
4th May 202111:36 amRNSDividend Update
27th Apr 20214:29 pmRNSAnnual Results for the year ended 31 December 2020
18th Sep 20207:00 amRNSInterim Results for the period to 30 June 2020
1st Jul 20202:01 pmRNSAnnual General Meeting
12th May 202010:00 amRNSAnnual Results for the year ended 31 Dec 2019
30th Jan 20207:00 amRNSUpdate
9th Dec 20194:15 pmRNSDirector Declaration
19th Sep 201912:10 pmRNSInterim Results for the six months ended 30 Jun 19
14th Aug 20197:00 amRNSChange of Name
1st Aug 20195:20 pmRNSResult of General Meeting
28th Jun 20199:00 amRNSShareholder Notification
29th Apr 20197:00 amRNSAnnual Results for year ended 31 December 2018
21st Sep 20187:00 amRNSInterim Results - six months ended 30th June 2018
2nd May 20187:00 amRNSAnnual Results
1st May 20187:00 amRNSDirector Appointment
11th Dec 20177:00 amRNSDirector-Designate Appointment
5th Oct 201712:33 pmRNSDirector Resignation
19th Sep 20174:11 pmRNSHalf-year Report
12th Jul 201711:08 amRNSShareholder Notification
26th Apr 201711:49 amRNSFinal Results
1st Dec 201611:43 amRNSDirector Appointment
27th Sep 20167:00 amRNSHalf-year Report
28th Jun 20167:00 amRNSDirector Appointment
13th May 20163:48 pmRNSHolding(s) in Company
22nd Apr 20167:00 amRNSFinal Results
15th Apr 20167:00 amRNSDividend Declaration
12th Feb 20167:00 amRNSUpdate on Board Changes
4th Dec 20153:11 pmRNSDirectorate Change
19th Oct 20152:09 pmRNSDisposal
22nd Sep 20152:59 pmRNSHalf Yearly Report
4th Jun 20159:55 amRNSTR-1: Notification of Major Interest in Shares
21st Apr 20159:32 amRNSFinal Results
16th Apr 20157:00 amRNSConditional Disposal
13th Mar 201510:14 amRNSDividend Declaration
18th Dec 201411:41 amRNSCancellation of Cumulative Preference Shares
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.